HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses
about
Leukocyte Ig-Like Receptors - A Model for MHC Class I Disease AssociationsHLA-dependent tumour development: a role for tumour associate macrophages?Crystal structures of the two membrane-proximal Ig-like domains (D3D4) of LILRB1/B2: alternative models for their involvement in peptide-HLA bindingStructural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen AllelesImmune activation and paediatric HIV-1 disease outcomeCharacterisation of bovine leukocyte Ig-like receptorsHIV subtype influences HLA-B*07:02-associated HIV disease outcome.Mutational escape in HIV-1 CTL epitopes leads to increased binding to inhibitory myelomonocytic MHC class I receptors.Disparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population.Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllersPost-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI StudyLILRB2 interaction with HLA class I correlates with control of HIV-1 infection.Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection.Innate immunity in acute HIV-1 infectionSystemic inhibition of myeloid dendritic cells by circulating HLA class I molecules in HIV-1 infection.Structural insights into activation of antiviral NK cell responsesDifferential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition grooveImmunogenetics of HIV disease.HLA/KIR restraint of HIV: surviving the fittestIncreased expression of intrinsic antiviral genes in HLA-B*57-positive individualsCis-trans interactions of cell surface receptors: biological roles and structural basis.The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection.HIV and HLA class I: an evolving relationshipThe genetic basis of resistance to HIV infection and disease progression.Unravelling the mechanisms of durable control of HIV-1.Regulation of neutrophil functions through inhibitory receptors: an emerging paradigm in health and disease.Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure.Post-Treatment Controllers: Role in HIV "Cure" Research.Host genetic variation and HIV disease: from mapping to mechanism.HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?HLA B51 is associated with faster AIDS progression among newly diagnosed HIV-infected individuals in Manitoba, Canada.Rapid human immunodeficiency virus disease progression is associated with human leukocyte antigen-B homozygocity and human leukocyte antigen-B51 in a cohort from Manitoba, Canada.Diversity of HLA-B*35 alleles and haplotypes among Croatians.Early SIV and HIV infection promotes the LILRB2/MHC-I inhibitory axis in cDCs.HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort.Mass Cytometry Analysis Reveals the Landscape and Dynamics of CD32a+ CD4+ T Cells From Early HIV Infection to Effective cART.Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control
P2860
Q26738439-ED469032-67F8-4267-BAA8-F81A2F2CA7C4Q27022124-0BF5FD20-A722-4CD6-9C86-0D33487D61EDQ27679716-258BB7CC-19C3-4F8E-96D0-7B62BA92AA13Q27703610-E0E4024B-C674-4E2F-B718-1452DA8E0B0CQ28086888-2C7575C0-AA06-4A20-B06A-7C26E76604D7Q28730806-3EECC6A1-DC67-4BE3-8E22-951D6C80F5F3Q33566546-9845BA70-FFB3-46AD-A136-C9EBCF6FDEBAQ33775626-50388B56-F72B-4318-ADB7-20F94CDC3BC2Q33999689-706B9901-654E-4A58-AA87-CC2EFF17844AQ34120046-D7CB3922-DA83-4512-8FBA-3F8099305094Q34629153-91CD4D27-3D6D-4D15-B51B-C7E4CF1A0A3CQ35112707-40BE184E-8F74-4B4E-9FB3-31EF75898945Q35664125-ED044C66-8A0B-4EBD-A681-8052F2F76227Q35696991-8861531F-1980-40A4-B74E-D061A5613432Q35842352-3658FBD2-189B-41D1-BF28-CE58942BBFD4Q36317668-5AB2DC85-88A3-4526-A4CD-83BE0854E41FQ36397593-B903907B-A282-45C2-AF3F-F9FABDEE8C1BQ36433849-087D650F-A805-485B-9F7C-05ACCF002C5AQ36989456-7A992194-678A-49A5-B807-EAAC8F8030A7Q37051248-80934FFB-1881-4FDA-923D-C0D636BE4ACDQ37238299-784FF918-5964-4254-AFEF-640E5330CAEAQ37921661-30F07C56-44FA-4170-A576-3E9AA4DA8879Q37949561-DCE48FB3-4DF9-433A-BB84-59EEEF04273FQ38045636-CE0F1A75-1175-491D-94B3-939E1717AA9EQ38096026-1780FFF8-B943-4C9E-87BD-4E7D617E5DAFQ38116710-427743B1-9FA4-4725-99D5-F6BCD4A94415Q38377860-B5BF8E2F-38A5-447E-A41E-E12DC50EB89FQ38607474-D06B9E73-A1C2-4840-B127-7F42E56465C0Q38701493-4A79A70C-0401-4882-9D12-16933B2F0C52Q39427526-C1713B6A-1447-40FF-A52C-626DF47323C9Q39739585-A313B6E1-6E0E-4075-B2A1-D1BD9BCB670CQ40097257-EF6F92A9-EA25-49F8-8F5E-59B2CC3F9140Q41058978-872883D6-44CE-4E0E-8F06-7C752721F618Q41279465-0EB867DB-5085-4DB3-A1A2-A4FA7F7A8181Q43437412-56F750CF-149E-4CF0-961B-E0A976E53DACQ44843573-6F6EEAFD-0773-46DB-B364-2CED2E99AB08Q46266036-3840A5A6-F42F-4C01-ADDD-B64F7B0CBD36Q55285568-7044ABF5-7807-4C11-AAD0-484EE4DEB4DEQ58702145-6635E2EC-DFB0-4587-A190-5752DE5D34E1
P2860
HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@ast
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@en
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@en-gb
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@nl
type
label
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@ast
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@en
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@en-gb
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@nl
prefLabel
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@ast
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@en
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@en-gb
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@nl
P2093
P2860
P921
P3181
P356
P1476
HLA-B*35-Px-mediated accelerat ...... tory immunoregulatory impulses
@en
P2093
Eric J Sundberg
James J Goedert
Jeffrey Lifson
Jinghe Huang
Liliana Preiss
Mathias Lichterfeld
Maureen P Martin
Patrick S Burke
Thai Duong Hong Cung
P2860
P304
P3181
P356
10.1084/JEM.20091386
P407
P577
2009-12-21T00:00:00Z